Literature DB >> 23727389

Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease.

Ji Hyun Son1, Doug Hyun Han, Kyung Joon Min, Baik Seok Kee.   

Abstract

Recent studies have suggested that depression might be an aggravating factor in Alzheimer's disease (AD). The aim of the study was to compare depressive symptoms and gray matter volume between AD patients with comorbid depression and patients with dementia only. Forty-nine patients with AD, 57 with mild cognitive impairment (MCI), and 50 healthy control subjects were assessed using the Consortium to Establish a Registry for Alzheimer's disease (CERAD) and the Geriatric Depression Scale (GDS). All magnetic resonance imaging (MRI)s were analyzed using voxel-based morphometry (VBM). Seventeen AD patients with depression versus 32 patients with dementia only showed decreased immediate recall for a word list (8.7±1.1 vs. 10.1±1.5, z=3.6, p<0.01) and constructional praxis scores (3.7±0.9 vs. 5.3±2.1, z=2.5, p=0.01). Compared to 32 patients with dementia, seventeen AD patients with depression showed decreased gray matter volume in the left inferior temporal gyrus (-56, -19, -31; KE=578, t=3.80, Puncorr<0.001). The MCI group showed decreased gray matter volume in the right hippocampal gyrus compared to healthy control group. Our results suggest that depressive symptoms may be associated with the volume changes of frontal and temporal lobe in patients with AD.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease (AD); Consortium to Establish a Registry for Alzheimer's disease (CERAD); Geriatric Depression Scale (GDS); Voxel based morphometry (VBM)

Mesh:

Year:  2013        PMID: 23727389     DOI: 10.1016/j.neulet.2013.05.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.

Authors:  Beatrix Krause-Sorio; Prabha Siddarth; Lisa Kilpatrick; Kelsey T Laird; Michaela M Milillo; Linda Ercoli; Katherine L Narr; Helen Lavretsky
Journal:  J Affect Disord       Date:  2020-05-24       Impact factor: 4.839

2.  Vertex-wise examination of depressive symptom dimensions and brain volumes in older adults.

Authors:  Molly E McLaren; Sarah M Szymkowicz; Andrew O'Shea; Adam J Woods; Stephen D Anton; Vonetta M Dotson
Journal:  Psychiatry Res Neuroimaging       Date:  2016-12-16       Impact factor: 2.376

3.  Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia.

Authors:  Maria Lage Barca; Dag Alnæs; Knut Engedal; Karin Persson; Rannveig Sakshaug Eldholm; Nikias Siafarikas; Ina Selseth Almdahl; Maria Stylianou-Korsnes; Ingvild Saltvedt; Geir Selbæk; Lars T Westlye
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2022-06-23

4.  Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer's Clinical Continuum.

Authors:  Inès Moulinet; Edelweiss Touron; Florence Mézenge; Sophie Dautricourt; Vincent De La Sayette; Denis Vivien; Natalie L Marchant; Géraldine Poisnel; Gaël Chételat
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

Review 5.  Volume, density, and thickness brain abnormalities in mild cognitive impairment: an ALE meta-analysis controlling for age and education.

Authors:  Philip J Raine; Hengyi Rao
Journal:  Brain Imaging Behav       Date:  2022-04-13       Impact factor: 3.224

6.  A specific pattern of gray matter atrophy in Alzheimer's disease with depression.

Authors:  Efstratios Karavasilis; Theodore P Parthimos; John D Papatriantafyllou; Sokratis G Papageorgiou; George Kapsas; Andrew C Papanicolaou; Ioannis Seimenis
Journal:  J Neurol       Date:  2017-08-30       Impact factor: 4.849

7.  Abnormal changes in functional connectivity between the amygdala and frontal regions are associated with depression in Alzheimer's disease.

Authors:  Zhongwei Guo; Xiaozheng Liu; Songquan Xu; Hongtao Hou; Xingli Chen; Zhenzhong Zhang; Wei Chen
Journal:  Neuroradiology       Date:  2018-09-21       Impact factor: 2.804

8.  Anatomical and functional brain abnormalities in unmedicated major depressive disorder.

Authors:  Xiao Yang; Xiaojuan Ma; Mingli Li; Ye Liu; Jian Zhang; Bin Huang; Liansheng Zhao; Wei Deng; Tao Li; Xiaohong Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-18       Impact factor: 2.570

9.  Voxel-based morphometry in Alzheimers disease and mild cognitive impairment: Systematic review of studies addressing the frontal lobe.

Authors:  Luís Gustavo Ribeiro; Geraldo Busatto
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

Review 10.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.